Showing results (211-220 of 231) with videos related to

Sort By:
Pageof 24
Archives of Gynecology and Obstetrics|February 16, 2018
Correction to: The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) Kommission Ovar, AGO Study Group, North-Eastern German Society of Gynaecologic Oncology (NOGGO), AGO Austria and AGO SwitzerlandA M Dueckelmann, D Fink, P Harter, et al.
Geburtshilfe Und Frauenheilkunde|March 5, 2016
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria and AGO Switzerland Regarding the Use of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Ovarian CancerP Harter, A du Bois, S Mahner, et al.
Gene Therapy|July 26, 2002
Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomasA G Zeimet, E Müller-Holzner, A Schuler, et al.
The American Journal of Pathology|December 14, 1999
Basic fibroblast growth factor synthesis by human peritoneal mesothelial cells: induction by interleukin-1M V Cronauer, S Stadlmann, H Klocker, et al.
Blood|August 15, 1996
Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancerB Eibl, H Schwaighofer, D Nachbaur, et al.
Cytokine|July 6, 2000
Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cellsB Abendstein, S Stadlmann, C Knabbe, et al.
British Journal of Cancer|February 9, 2012
Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trialV Seebacher, S Polterauer, C Grimm, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 5, 2015
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-upN Colombo, C Creutzberg, F Amant, et al.
British Journal of Cancer|July 28, 2012
Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patientsU Wagner, C Marth, R Largillier, et al.
Oncogene|April 26, 2011
Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancerD Reimer, M Hubalek, H Kiefel, et al.
Pageof 24